The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial-Reference-Cited by-同舟云学术

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Published:2010-06-18 Issue:9 Volume:127 Page:2209-2221
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Heiss Markus M.,Murawa Pawel,Koralewski Piotr,Kutarska Elzbieta,Kolesnik Olena O.,Ivanchenko Vladimir V.,Dudnichenko Alexander S.,Aleknaviciene Birute,Razbadauskas Arturas,Gore Martin,Ganea-Motan Elena,Ciuleanu Tudor,Wimberger Pauline,Schmittel Alexander,Schmalfeldt Barbara,Burges Alexander,Bokemeyer Carsten,Lindhofer Horst,Lahr Angelika,Parsons Simon L.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Malignant ascites;Parsons;Br J Surg,1996

2. Pattern and prognostic factors in patients with malignant ascites: a retrospective study;Ayantunde;Ann Oncol,2007

3. The pathogenesis of malignant ascites;Tamsma;Cancer Treat Res,2007

4. New strategies for the management of malignant ascites;Preston;Eur J Cancer Care,1995

Cited by 467 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies;The Lancet Haematology;2024-09

2. Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors;International Immunopharmacology;2024-09

3. Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors;International Journal of Molecular Sciences;2024-08-27

4. Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors;Molecular Diagnosis & Therapy;2024-08-22

5. Chimeric antigen receptor-T cells targeting epithelial cell adhesion molecule antigens are effective in the treatment of colorectal cancer;BMC Gastroenterology;2024-08-06